187 related articles for article (PubMed ID: 22454481)
81. ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Donawho CK; Luo Y; Luo Y; Penning TD; Bauch JL; Bouska JJ; Bontcheva-Diaz VD; Cox BF; DeWeese TL; Dillehay LE; Ferguson DC; Ghoreishi-Haack NS; Grimm DR; Guan R; Han EK; Holley-Shanks RR; Hristov B; Idler KB; Jarvis K; Johnson EF; Kleinberg LR; Klinghofer V; Lasko LM; Liu X; Marsh KC; McGonigal TP; Meulbroek JA; Olson AM; Palma JP; Rodriguez LE; Shi Y; Stavropoulos JA; Tsurutani AC; Zhu GD; Rosenberg SH; Giranda VL; Frost DJ
Clin Cancer Res; 2007 May; 13(9):2728-37. PubMed ID: 17473206
[TBL] [Abstract][Full Text] [Related]
82. Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Yang J; Park Y; Zhang H; Gao X; Wilson E; Zimmer W; Abbott L; Zhang C
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1208-16. PubMed ID: 19666844
[TBL] [Abstract][Full Text] [Related]
83. Vitamin E improves testicular damage in streptozocin-induced diabetic rats, via increasing vascular endothelial growth factor and poly(ADP-ribose) polymerase-1.
Omar SS; Aly RG; Badae NM
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29164711
[TBL] [Abstract][Full Text] [Related]
84. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
[TBL] [Abstract][Full Text] [Related]
85. Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats.
Ishida K; Matsumoto T; Taguchi K; Kamata K; Kobayashi T
Acta Physiol (Oxf); 2013 Jan; 207(1):130-41. PubMed ID: 22759594
[TBL] [Abstract][Full Text] [Related]
86. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.
Krainz T; Lamade AM; Du L; Maskrey TS; Calderon MJ; Watkins SC; Epperly MW; Greenberger JS; Bayır H; Wipf P; Clark RSB
ACS Chem Biol; 2018 Oct; 13(10):2868-2879. PubMed ID: 30184433
[TBL] [Abstract][Full Text] [Related]
87. PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.
Cardinale A; Paldino E; Giampà C; Bernardi G; Fusco FR
PLoS One; 2015; 10(8):e0134482. PubMed ID: 26252217
[TBL] [Abstract][Full Text] [Related]
88. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
89. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
Zhou W; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
J Vasc Surg; 2005 May; 41(5):861-8. PubMed ID: 15886672
[TBL] [Abstract][Full Text] [Related]
90. Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase.
Korkmaz-Icöz S; Radovits T; Loganathan S; Li S; Ruppert M; Benke K; Brlecic P; Szabó C; Karck M; Szabó G
Eur J Cardiothorac Surg; 2017 May; 51(5):829-835. PubMed ID: 28204209
[TBL] [Abstract][Full Text] [Related]
91. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
[TBL] [Abstract][Full Text] [Related]
92. Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Pharmacol Res; 2012 Jul; 66(1):41-50. PubMed ID: 22465219
[TBL] [Abstract][Full Text] [Related]
93. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
[TBL] [Abstract][Full Text] [Related]
94. Pirfenidone Is a Vasodilator: Involvement of K
Beck L; Pinilla E; Arcanjo DDR; Hernanz R; Prat-Duran J; Petersen AG; Köhler R; Sheykhzade M; Comerma-Steffensen S; Simonsen U
Front Pharmacol; 2020; 11():619152. PubMed ID: 33643042
[TBL] [Abstract][Full Text] [Related]
95. Chloroquine differentially modulates coronary vasodilation in control and diabetic mice.
Zhang Q; Tsuji-Hosokawa A; Willson C; Watanabe M; Si R; Lai N; Wang Z; Yuan JX; Wang J; Makino A
Br J Pharmacol; 2020 Jan; 177(2):314-327. PubMed ID: 31503328
[TBL] [Abstract][Full Text] [Related]
96. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.
Xu B; Chiu J; Feng B; Chen S; Chakrabarti S
Diabetes Metab Res Rev; 2008; 24(5):404-12. PubMed ID: 18351623
[TBL] [Abstract][Full Text] [Related]
97. Poly(ADP-ribose) Polymerase-1: An Update on Its Role in Diabetic Retinopathy.
Sun J; Chen L; Chen R; Lou Q; Wang H
Discov Med; 2021; 32(165):13-22. PubMed ID: 35219352
[TBL] [Abstract][Full Text] [Related]
98. Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.
Mohammad G; Siddiquei MM; Abu El-Asrar AM
Mediators Inflamm; 2013; 2013():510451. PubMed ID: 24347828
[TBL] [Abstract][Full Text] [Related]
99. Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.
Katz PS; Trask AJ; Souza-Smith FM; Hutchinson KR; Galantowicz ML; Lord KC; Stewart JA; Cismowski MJ; Varner KJ; Lucchesi PA
Basic Res Cardiol; 2011 Nov; 106(6):1123-34. PubMed ID: 21744279
[TBL] [Abstract][Full Text] [Related]
100. Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension.
Shafiq M; Lone ZR; Abdulkareem AO; Kaur G; Navya S; Singh H; Jagavelu K; Hanif K
Pulm Pharmacol Ther; 2023 Jun; 80():102200. PubMed ID: 36842770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
